These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3142427)

  • 1. [Actilyse: biological aspects].
    Samama M; Cormier B; Conard J
    Arch Mal Coeur Vaiss; 1988 May; 81 Spec No():51-7. PubMed ID: 3142427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator.
    Richard G; Lerche RC; Knospe V; Zeumer H
    Ophthalmology; 1999 Apr; 106(4):768-73. PubMed ID: 10201601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis and the risk of venous and arterial thrombosis.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tissue-type plasminogen activator--a fibrinolytic preparation].
    Makarov VA
    Farmakol Toksikol; 1989; 52(2):90-3. PubMed ID: 2501106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present-day thrombolytic therapy: therapeutic agents--pharmacokinetics and pharmacodynamics.
    Bell WR
    Rev Cardiovasc Med; 2002; 3 Suppl 2():S34-44. PubMed ID: 12556741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vampire bat salivary plasminogen activator evokes minimal bleeding relative to tissue-type plasminogen activator as assessed by a rabbit cuticle bleeding time model.
    Mellott MJ; Ramjit DR; Stabilito II; Hare TR; Senderak ET; Lynch JJ; Gardell SJ
    Thromb Haemost; 1995 Mar; 73(3):478-83. PubMed ID: 7545321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of fibrinolysis laboratory tests: a review.
    Prisco D; Conti AA; Giurlani L; Falciani M
    Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhibitor of activated thrombin activatable fibrinolysis inhibitor (TAFIa) - part II: enhancement of both exogenous and endogenous fibrinolysis in animal models of thrombosis.
    Wang YX; da Cunha V; Vincelette J; Zhao L; Nagashima M; Kawai K; Yuan S; Emayan K; Islam I; Hosoya J; Sullivan ME; Dole WP; Morser J; Buckman BO; Vergona R
    Thromb Haemost; 2007 Jan; 97(1):54-61. PubMed ID: 17200771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
    Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombolysis in central retinal artery occlusion using alteplase].
    Mach R; Procházka J
    Cesk Slov Oftalmol; 2008 Nov; 64(6):245-8. PubMed ID: 19110967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Actilyse (a recombinant tissue-type plasminogen activator] in the treatment of acute myocardial infarct. Comparison of the effects of Actilyse and streptokinase].
    Bastecký J; Kvasnicka J; Macek K; Malý J; Rozsíval V; Chrobák L; Gajdosová I; Skopecková H; Wasylivová V; Ettlerová E
    Vnitr Lek; 1994 May; 40(5):293-8. PubMed ID: 8023469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.